Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Montaka Global Investments, an investment management company, released its fourth quarter 2024 investor letter. A copy of the ...

Google's strong market position is maintained through advanced algorithms, customer loyalty, and an extensive ecosystem. Read ...

Alphabet ( GOOG 1.63%) ( GOOGL 1.58%) stock got a small lift on Tuesday, rising 2% higher through 10:30 a.m. ET. The move ...

The Google stock price has jumped to a record high this year. Alphabet has become the cheapest company in the Magnificent 7 ...

Indonesia's antitrust agency on Tuesday ordered Google to pay fines of around 202 billion rupiah ($12.4 million) for unfair ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

CEO Sundar Pichai described current trends as "extraordinary," projecting confidence in the company's forward outlook. Wall ...

Google CEO Sundar Pichai is attending Donald Trump's inauguration, a source familiar with the matter tells BI. He joins a ...